Kruijshaar Michelle E, Siersema Peter D, Janssens A Cecile J W, Kerkhof Marjon, Steyerberg Ewout W, Essink-Bot Marie-Louise
Department of Public Health, Erasmus MC-University Medical Center Rotterdam, the Netherlands.
Gastrointest Endosc. 2007 Jan;65(1):26-30. doi: 10.1016/j.gie.2006.05.030.
The risk of developing esophageal adenocarcinoma (EAC) for patients with Barrett's esophagus (BE) is approximately 0.5% per year.
To investigate how patients with BE estimate and perceive their risk of developing EAC.
Questionnaire study.
Patients with BE who were undergoing surveillance endoscopy based on histologic and flow cytometric results.
A total of 192 patients with BE were included.
Individual patients were asked to estimate the numerical risk to develop EAC for patients with BE in general and for themselves. How patients perceived their own risk was measured on a scale from "very small" to "very large."
At least 1 question was filled out by 169 patients (88% response). Sixty percent of respondents underestimated the numerical risk for patients with BE, in general, to develop EAC, while even more patients (69%) underestimated their own risk. Most respondents perceived their own risk as very small or small (63%).
Risk estimations may depend on the response scale used.
Most patients with BE underestimated the numerical risk and perceived their risk of developing EAC as (very) low. Despite a low perceived risk, all patients in this group adhered to endoscopic surveillance.
巴雷特食管（BE）患者发生食管腺癌（EAC）的风险约为每年0.5%。
调查BE患者如何估计和认识自己发生EAC的风险。
问卷调查研究。
根据组织学和流式细胞术结果接受监测性内镜检查的BE患者。
共纳入192例BE患者。
要求个体患者估计BE患者总体发生EAC的数字风险以及自身发生EAC的数字风险。采用从“非常小”到“非常大”的量表衡量患者对自身风险的认识。
169例患者（88%的应答率）至少填写了1个问题。60%的应答者低估了BE患者总体发生EAC的数字风险，而更多患者（69%）低估了自身风险。大多数应答者认为自己的风险非常小或小（63%）。
风险估计可能取决于所使用的应答量表。
大多数BE患者低估了数字风险，并认为自己发生EAC的风险（非常）低。尽管感知到的风险较低，但该组所有患者均坚持内镜监测。
